Antitrust

Regeneron Secures $400 Million Victory in Landmark Antitrust Ruling Against Amgen

by

Bridgewater, New Jersey — A jury has awarded Regeneron Pharmaceuticals Inc. $400 million in a significant antitrust case against rival Amgen Inc. This landmark decision underscores the ongoing legal battles over market competition and patent rights in the biotechnology sector. The case revolved around claims that Amgen engaged in anti-competitive practices that harmed Regeneron’s business interests. The jury’s verdict reinforces Regeneron’s position, alleging that Amgen’s actions restricted the market and competitive landscape for vital medications. Both companies are significant players in the pharmaceutical industry, with a focus on cutting-edge treatments. Regeneron, known for its work … Read more

Federal Judge Halts ATP’s Retaliation Tactics, Boosts Player Protections Amid Antitrust Lawsuit

by

A federal judge in New York has determined that the ATP cannot take action against players participating in a lawsuit against the organization or those contemplating joining it. U.S. District Court Judge Margaret Garnett’s ruling marks a significant development for the Professional Tennis Players Association (PTPA), which initiated an antitrust lawsuit against the ATP, the WTA, the ITF, and the ITIA in March. The legal action stems from claims that the ATP attempted to dissuade players from supporting the PTPA’s efforts. Following the lawsuit’s announcement, the ATP distributed a letter for players to sign, which … Read more

Meta Faces Major Legal Challenge as Antitrust Trial Kicks Off

by

San Francisco, California – A major antitrust trial involving Meta, the parent company of Facebook, Instagram, and WhatsApp, commenced this week, posing significant implications for the tech giant’s future operations and potentially reshaping the U.S. tech landscape. The U.S. Federal Trade Commission (FTC) has accused Meta of operating a monopoly in the social networking domain, violating antitrust laws and stifling competition through strategic acquisitions and practices. At the heart of the lawsuit is Meta’s past acquisitions, specifically Instagram in 2012 and WhatsApp in 2014, which the FTC argues were purchased to neutralize competition. The federal … Read more

Switzerland’s Sandoz Takes Legal Action Against Amgen, Alleging Antitrust Violations in the US

by

Basel, Switzerland – Sandoz, a division of Swiss pharmaceutical giant Novartis AG, has launched an antitrust lawsuit against Amgen Inc. in the United States, accusing the American biotechnology firm of engaging in anti-competitive practices. The legal action, filed in the U.S. District Court for the Eastern District of Pennsylvania, alleges that Amgen has been blocking biosimilar competition to its white blood cell-boosting drugs, Neulasta and Neupogen, thus monopolizing the market. Sandoz argues that Amgen has set up a series of obstacles – ranging from questionable patents to exclusionary contracts with healthcare providers – effectively stifling … Read more